Richwood Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.71M Sell
6,425
-445
-6% -$455K 5.42% 4
2026
Q1
$6.32M Buy
6,870
+20
+0.3% +$20.3K 4.87% 4
2025
Q4
$7.25M Sell
6,850
-245
-3% -$234K 5.2% 4
2025
Q3
$5.41M Sell
7,095
-25
-0.4% -$18.6K 4.24% 4
2025
Q2
$5.55M Buy
7,120
+55
+0.8% +$42.7K 4.56% 5
2025
Q1
$5.84M Buy
7,065
+117
+2% +$97.4K 4.96% 4
2024
Q4
$5.36M Sell
6,948
-43
-0.6% -$35.6K 4.47% 5
2024
Q3
$6.19M Sell
6,991
-147
-2% -$132K 5.12% 4
2024
Q2
$6.46M Buy
7,138
+133
+2% +$106K 5.66% 4
2024
Q1
$5.45M Sell
7,005
-88
-1% -$62.6K 4.84% 4
2023
Q4
$4.13M Sell
7,093
-290
-4% -$169K 3.88% 4
2023
Q3
$3.97M Sell
7,383
-5
-0.1% -$2.58K 4.04% 4
2023
Q2
$3.46M Sell
7,388
-269
-4% -$113K 3.38% 4
2023
Q1
$2.63M Sell
7,657
-163
-2% -$55K 2.62% 5
2022
Q4
$2.86M Sell
7,820
-180
-2% -$63.8K 2.88% 5
2022
Q3
$2.59M Sell
8,000
-126
-2% -$39.9K 2.84% 5
2022
Q2
$2.63M Sell
8,126
-495
-6% -$149K 2.66% 6
2022
Q1
$2.47M Buy
8,621
+65
+0.8% +$16.7K 2.2% 7
2021
Q4
$2.36M Buy
+8,556
New +$2.17M 2.07% 7

Other funds holding LLY

Richwood Investment Advisors's LLY Position: Q2 2026 in Review

Richwood Investment Advisors reduced its Eli Lilly (LLY) stake by 6.5% in Q2 2026, selling an estimated $455K and leaving 6,425 shares worth $7.71M. The position accounts for 5.42% of the portfolio, ranked #4.

Richwood Investment Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Richwood Investment Advisors held 6,425 shares of Eli Lilly worth $7.71M as of Q2 2026.
  • Richwood Investment Advisors sold 445 Eli Lilly shares in Q2 2026, an estimated $455K.
  • Eli Lilly made up 5.42% of Richwood Investment Advisors's portfolio in Q2 2026, its #4 holding.
  • Richwood Investment Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Richwood Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.